Research ArticleCANCER

Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds

See allHide authors and affiliations

Science Advances  22 Jan 2021:
Vol. 7, no. 4, eabd7851
DOI: 10.1126/sciadv.abd7851

Article Information

vol. 7 no. 4

PubMed: 
Online ISSN: 
History: 
  • Received for publication July 12, 2020
  • Accepted for publication December 4, 2020
  • .

Author Information

  1. Haiyan Wang1,2,*,
  2. Shasha Li2,*,
  3. Qianyu Wang3,*,
  4. Zhengshuo Jin2,
  5. Wei Shao2,
  6. Yan Gao4,
  7. Lu Li3,
  8. Kequan Lin3,
  9. Lin Zhu3,
  10. Huili Wang2,
  11. Xuebin Liao4 and
  12. Dong Wang2,5,6,7,
  1. 1Department of Pathology, School of Medicine, Qinghai University, Xining 810001, China.
  2. 2Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China.
  3. 3School of Life Sciences, Tsinghua University, Beijing 100084, China.
  4. 4School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.
  5. 5Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Sichuan 610041, China.
  6. 6Center for Synthetic and Systems Biology, Tsinghua University, Beijing 100084, China.
  7. 7State Key Laboratory of Southwestern Chinese Medicine Resources, School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  1. Corresponding author. Email: dwang{at}cdutcm.edu.cn
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: January 2021 to June 2021

AbstractFullPdf
Jan 20211872197706
Feb 202134717368
Mar 202152605414
Apr 202136396192
May 202125534200
Jun 202129245123

Stay Connected to Science Advances

Navigate This Article